Prevalence of hepatic steatosis and metabolic associated fatty liver disease among female breast cancer survivors.

Author: Shen TIAN ¹ ; Hao LI ¹ ; Renhua LI ² ; Liang RAN ³ ; Shu LI ¹ ; Juan WU ¹ ; Zhou XU ⁴ ; Xinyu LIANG ¹ ; Yuling CHEN ¹ ; Jun XIAO ¹ ; Jiaying WEI ¹ ; Chenyu MA ¹ ; Jingyu SONG ¹ ; Ruiling SHE ¹ ; Kainan WU ¹ ; Lingquan KONG ¹
Author Information

1. Department of Endocrine and Breast Surgery, The First Affiliated Hospital of Chongqing Medical University, Chongqing 400016, China.
2. Department of Infectious Diseases, The First Affiliated Hospital of Chongqing Medical University, Chongqing 400016, China.
3. The Health Management Center of the First Affiliated Hospital of Chongqing Medical University, Chongqing 400016, China.
4. Department of Thyroid and Breast Surgery, Affiliated Hospital of North Sichuan Medical College, Nanchong, Sichuan 637000, China.
Publication Type:Journal Article
MeSH: Humans; Female; Prevalence; Breast Neoplasms; Cancer Survivors; Non-alcoholic Fatty Liver Disease; Liver
From: Chinese Medical Journal 2022;135(19):2372-2374
CountryChina
Language:English